A detailed history of Fayez Sarofim & CO transactions in Boston Scientific Corp stock. As of the latest transaction made, Fayez Sarofim & CO holds 3,793 shares of BSX stock, worth $329,953. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,793
Previous 12,719 70.18%
Holding current value
$329,953
Previous $979,000 67.62%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$72.96 - $84.0 $651,240 - $749,784
-8,926 Reduced 70.18%
3,793 $317,000
Q2 2024

Aug 14, 2024

SELL
$67.33 - $77.71 $471 - $543
-7 Reduced 0.06%
12,719 $979,000
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $403 - $480
7 Added 0.06%
12,726 $871,000
Q4 2023

Feb 14, 2024

SELL
$48.64 - $57.81 $64,399 - $76,540
-1,324 Reduced 9.43%
12,719 $735,000
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $448,447 - $488,565
8,935 Added 174.92%
14,043 $741,000
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $253,969 - $279,101
5,108 New
5,108 $276,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $125B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Fayez Sarofim & CO Portfolio

Follow Fayez Sarofim & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.